What are the differential diagnoses for elevated hemoglobin and hematocrit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnoses for Elevated Hemoglobin and Hematocrit

The differential diagnosis for elevated hemoglobin and hematocrit divides into three major categories: primary polycythemia (polycythemia vera), secondary erythrocytosis (hypoxia-driven or hypoxia-independent), and relative polycythemia from plasma volume depletion. 1

Primary Polycythemia

Polycythemia Vera (PV)

  • JAK2 mutation-positive myeloproliferative neoplasm is the most important primary cause, detected in up to 97% of PV cases when both JAK2 V617F and exon 12 mutations are tested. 2, 1, 3
  • WHO diagnostic criteria require either: (a) both major criteria (hemoglobin >18.5 g/dL in men or >16.5 g/dL in women AND JAK2 mutation) plus one minor criterion, OR (b) the first major criterion plus two minor criteria. 2, 1, 4
  • Minor criteria include: bone marrow hypercellularity with trilineage growth, subnormal serum erythropoietin level, or endogenous erythroid colony formation. 2, 4
  • Associated features that increase suspicion include thrombocytosis, leukocytosis, splenomegaly, aquagenic pruritus (intense itching after water contact), or unusual thrombosis. 1, 3

Other Primary Causes

  • Erythropoietin receptor mutations cause primary familial erythrocytosis with low erythropoietin levels. 1, 5, 6
  • SH2B3 gene mutations have been implicated in primary congenital erythrocytosis. 5

Secondary Erythrocytosis: Hypoxia-Driven

Pulmonary Causes

  • Chronic obstructive pulmonary disease (COPD) causes tissue hypoxia that stimulates erythropoietin production, leading to compensatory erythrocytosis. 1, 3
  • Obstructive sleep apnea produces nocturnal hypoxemia that drives erythropoietin production and should be evaluated with sleep study if suspected. 1, 3
  • Chronic lung disease of any etiology causing arterial oxygen saturation <92% indicates secondary polycythemia due to hypoxemia. 1, 4

Cardiac Causes

  • Cyanotic congenital heart disease with right-to-left shunting results in arterial hypoxemia, triggering compensatory erythrocytosis to optimize oxygen transport. 1

Environmental and Lifestyle

  • High altitude residence causes physiological increases in hemoglobin levels, with specific adjustments needed based on elevation (e.g., +1.9 g/dL at 3,000 meters, +3.5 g/dL at 4,000 meters). 1
  • Smoking causes "smoker's polycythemia" through chronic carbon monoxide exposure, which creates tissue hypoxia and stimulates erythropoietin production; this resolves with smoking cessation. 1, 3

Hemoglobin Variants

  • High-oxygen-affinity hemoglobin variants (HBB, HBA mutations) prevent normal oxygen release to tissues, causing compensatory erythrocytosis. 1, 5, 6
  • BPGM mutations decrease production of 2,3-bisphosphoglycerate, increasing hemoglobin-oxygen affinity and triggering erythrocytosis. 1, 5, 6

Genetic Oxygen-Sensing Pathway Defects

  • Chuvash polycythemia (VHL gene mutation) disrupts the hypoxia-sensing pathway. 1, 5, 6
  • EPAS1 mutations (HIF-2α gene) cause inappropriate erythropoietin production. 5, 6
  • EGLN1 mutations (PHD2 gene) impair oxygen sensing. 5, 6
  • PIEZO1 mutations have recently been associated with erythrocytosis. 5

Secondary Erythrocytosis: Hypoxia-Independent

Malignancy-Associated

  • Renal cell carcinoma can produce erythropoietin independently, causing elevated hemoglobin levels. 1
  • Hepatocellular carcinoma may secrete erythropoietin autonomously. 1
  • Pheochromocytoma, uterine leiomyoma, and meningioma are other erythropoietin-producing tumors. 1

Renal Causes

  • Renal cysts, hydronephrosis, or other renal disease can cause inappropriate erythropoietin production. 1

Iatrogenic

  • Testosterone therapy (prescribed or unprescribed) can cause erythrocytosis and should be considered in the differential diagnosis, particularly in young adults. 1
  • Erythropoietin therapy directly causes elevated hemoglobin levels. 1

Relative Polycythemia (Plasma Volume Depletion)

Volume Depletion States

  • Dehydration is the most common cause of elevated hematocrit and should be assessed first by reviewing fluid intake history and recent losses. 1, 3
  • Diuretic use can cause plasma volume depletion leading to relative polycythemia without true increase in red cell mass. 1, 3
  • Burns cause significant plasma volume loss. 1

Stress Polycythemia

  • Gaisböck syndrome (stress polycythemia) represents relative polycythemia in the absence of identifiable volume depletion. 1

Critical Diagnostic Considerations

When to Suspect Primary vs. Secondary

  • Low or subnormal serum erythropoietin suggests primary polycythemia (PV), though up to 30% of confirmed PV patients may have normal erythropoietin values. 1, 4
  • Elevated erythropoietin mandates evaluation for secondary causes of erythrocytosis. 4
  • Normal erythropoietin does not exclude either diagnosis and requires further workup. 4

Common Pitfalls

  • Iron deficiency frequently coexists with erythrocytosis and can mask the true degree of elevation by lowering hemoglobin while red cell mass remains elevated; serum ferritin and transferrin saturation are essential to evaluate iron status. 1, 3
  • Do not assume dehydration without clinical confirmation, as a near-normal hemoglobin value may actually suggest dehydration masking anemia. 3
  • Hemoglobin is more reliable than hematocrit for diagnosis because hematocrit can falsely increase by 2-4% with prolonged sample storage and is affected by hyperglycemia, while hemoglobin remains stable. 1

Red Flags Requiring Urgent Evaluation

  • Hemoglobin >20 g/dL and hematocrit >65% with symptoms of hyperviscosity (headache, visual disturbances, dizziness) requires urgent therapeutic phlebotomy after excluding dehydration. 1, 3
  • Positive JAK2 mutation requires immediate hematology referral for management of polycythemia vera. 3
  • Unexplained splenomegaly with elevated blood counts mandates hematology evaluation. 3

References

Guideline

Assessment Protocol for Incidental Erythrocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Polycythemia Vera and Secondary Erythrocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis of Polycythemia Vera – Role of Erythropoietin and Molecular Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.